application/atom+xml

Posts Tagged ‘Results’

MBIA Inc. Reports First Quarter 2010 Financial Results

MBIA Inc. Reports First Quarter 2010 Financial Results
ARMONK, N.Y.—-MBIA Inc. today reported Adjusted Book Value per share of $36.01 as of March 31, 2010, compared with $36.35 as of December 31, 2009. ABV declined modestly in the first quarter as increased credit impairments on insured credit derivatives and insurance incurred losses exceeded earnings from all other sources.

Read more on Business Wire via Yahoo! Finance



Related Blogs

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

American Defense Systems Reports First Quarter 2010 Results

American Defense Systems Reports First Quarter 2010 Results
Q1 Revenues Increased 63% to Record $15.4 Million

Read more on Marketwire



Related Blogs

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results

Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) (“Biostar” or “the Company”), a Xianyang- based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules (“Xin Aoxing”), and a variety of pharmaceutical products, today announced financial results of the first quarter ended March 31, 2010. read more

Read more on SYS-CON Media



Related Blogs

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

China Biologic Products Announces First Quarter 2010 Results

China Biologic Products Announces First Quarter 2010 Results
China Biologic Products, Inc. (Nasdaq: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. (“Taibang”) and Guiyang Dalin Biologic Technologies Co., Ltd. (“Dalin”) and its equity investment in Xi’an …

Read more on SYS-CON Media



Related Blogs

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Tix Corporation Reports 2010 First Quarter Results

Tix Corporation Reports 2010 First Quarter Results
STUDIO CITY, Calif.—-Tix Corporation , a leading integrated entertainment company providing discount and premium ticketing services, event and branded merchandising, and production / promotion of live concert and theatrical events, today reported results for the first quarter ended March 31, 2010.

Read more on Business Wire via Yahoo! Finance



Related Blogs

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace